Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$209,530
-$8,398 QoQ
Shares Held
1,105
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,181
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aureus Asset Management, LLC holds $14,021,737 across 9 Drug Manufacturers - General names. AZN ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,359 | $4,028,885 | |
| 2 | JNJ |
Johnson & Johnson
|
9,201 | $2,336,777 | |
| 3 | AMGN |
Amgen Inc
|
4,987 | $1,805,892 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,833 | $1,520,540 | |
| 6 | NVO |
Novo Nordisk A S
|
27,220 | $1,304,926 | |
| 7 | NVS |
Novartis AG
|
5,586 | $875,437 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,105 | $209,530 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $209,530 | 1,105 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $217,928 | 1,105 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||